Chief Investigator: Dr Ashlea Bartram [Early Career Researcher] Funding Amount : $39,700 Recipient: Flinders University Overview: Zero-alcohol beverages (<0.5% alcohol) resemble alcohol in appearance and taste, often using alcohol brands. These beverages
Chief Investigator: Dr Moira Walsh [Early Career Researcher] Funding Amount : $39,997 Recipient: Flinders University Overview: Young carers are often not centred in research despite their significant contributions. This is especially true
Chief Investigator: Dr Karissa Barthelson Funding Amount : $73,682 Recipient: Flinders University Overview: Our unique research strategy compares gene expression and behaviour patterns using machine learning in zebrafish models of two childhood
Chief Investigator: A/Prof Dani-Louise Dixon Funding Amount : $99,973 Recipient: Flinders University Overview: Bronchiolitis, the most common severe respiratory tract illness in infants, remains a major cause of hospitalisation in Australia. Currently, there
Chief Investigator: Dr Anya Arthurs [Early Career Researcher] Funding Amount : $39,999 Recipient: Flinders University Overview: Growth restricted babies are more likely to suffer stillbirth or neonatal death. Molecules called circular RNAs (circRNAs) accumulate
Channel 7 Children’s Research Foundation (CRF) is pleased to announce the appointment of Professor Amanda Page to its Honorary Board of Directors, effective September 2023. Amanda comes to CRF as
Healthy Development Adelaide (HDA) and Channel 7 Children’s Research Foundation (CRF) PhD Excellence Award 2024 The CRF PhD Excellence Award is $5,000 per annum for up to 3 years only
Discover who will undertake CRF-supported research in 2024 to improve the health, education and/or welfare of children. We invite you to be a part of this exciting celebration as we
Join us for a special event dedicated to honoring the outstanding researchers in kids health, education, and welfare in South Australia. This in-person gathering will take place on Thursday, October 26,
Media Release : University of South Australia 13 September 2023 The innovation – which has undergone advanced pre-clinical trials – is effective against a broad range of drug-resistant bacterial cells,